Article

Sleep apnea and hypertension - The role of peripheral chemoreceptors and the sympathetic system

Universidad Autónoma de Madrid, Madrid, Madrid, Spain
Chest (Impact Factor: 7.13). 11/2009; 136(5 Suppl):e30. DOI: 10.1378/chest.117.5.1417
Source: PubMed

ABSTRACT Study objectives: To examine the central inspiratory drive response to hypoxia in patients with obstructive sleep apnea (OSA), according to their circadian BP profile, and in healthy control subjects. Another objective was to evaluate the relationships among sleep architecture, hypoxic sensitivity, urinary catecholamine excretion, and BP in OSA patients, Patients and interventions: Polysomnography, 24-h ambulatory BP recording, and urinary excretion of catecholamines were simultaneously examined in 24 consecutive OSA patients and 11 healthy subjects. OSA patients were categorized as being normotensive (type 1), having BP elevation only during sleep (type 2), and as being hypertensive with elevated BP at an times (type 3), The response of mouth occlusion pressure at 0.1 s after onset (P-0.1) to progressive isocapnic hypoxic stimulation was measured, Results: There was a significant difference in the P-0.1 response to hypoxia among control subjects ([mean +/- SD] 0.353 +/- 0.129 cm H2O/%) and type 1 (0.228 +/- 0.062 cm H2O/%), type 2 (0.345 +/- 0.106 cm H2O/%), and type 3 (0.508 +/- 0.118 cm H2O/%) OSA patients. In OSA patients, chemosensitivity was related to the apnea-hypopnea index and to the nocturnal excretion of epinephrine, Significant relationships between the nocturnal excretion of epinephrine and BP were noted. On multiple linear regression analysis, the P-0.1 response to hypoxia was the only variable significantly related to diurnal (r(2) = 0.364; p = 0.005) and nocturnal mean BP (r(2) = 0.461; p = 0.002). Conclusion: The findings of the present study suggest a possible mediating role of the peripheral chemosensitivity in the association between sleep apnea and hypertension.

0 Followers
 · 
70 Views
 · 
0 Downloads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objetivo: Construcción de un algoritmo para el diagnóstico del síndrome de apneas-hipopneas durante el sueño (SAHS) mediante el uso optimizado y secuencial de la pulsioximetría nocturna (PN) y la poligrafía respiratoria AutoSet® (AS) en pacientes con alta sospecha clínica de SAHS. Métodos: Realización simultánea de una PN y AS en 145 pacientes con alta sospecha clínica de SAHS (al menos dos de: roncopatía crónica, apneas presenciadas y repetidas, y somnolencia diurna patológica). El diagnóstico de SAHS se realizó con un índice de apneas-hipopneas (IAH) (obtenido mediante AS) = 10. Para la construcción del algoritmo diagnóstico se siguieron los siguientes pasos: cálculo de la prevalencia de SAHS; cálculo del mejor punto de corte diagnóstico en el índice de desaturaciones mayores o iguales al 4% (ID 4%) respecto al IAH; análisis del valor predictivo positivo (VPP) y negativo (VPN) para dicho valor y correlación y concordancia entre ID 4% e IAH según la existencia y gravedad de SAHS. Resultados: La prevalencia global de SAHS fue del 83,4%. El mejor punto de corte se obtuvo para un ID 4% = 10 (sensibilidad [S]: 82%; especificidad [E]: 83%). Los VPP y VPN para la prevalencia calculada fueron de 0,95 y 0,29, respectivamente. La correlación y concordancia global entre el ID 4% e IAH fue de 0,84 y 0,93, respectivamente. En pacientes sin SAHS fueron de 0,49 y 0,35, y ambas aumentaron progresivamente en SAHS leves, moderados y graves (0,90 y 0,95, respectivamente, en SAHS graves). Con todos estos datos se construyó el algoritmo diagnóstico según el cual la obtención de un ID 4% = 30 en la PN (S: 72%; E: 100%) evitaría la realización de una AS posterior, mientras que un ID 4% < 30 haría necesaria la realización de estudios posteriores (AS o PSG en caso de negatividad de la AS), dada la alta prevalencia de SAHS en nuestra serie. Conclusiones: La utilización secuencial de la PN y la AS permite ahorrar un número importante de estudios polisomnográficos en poblaciones con alta sospecha clínica de SAHS.
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective To construct an algorithm for the diagnosis of sleep apnea/hypopnea syndrome (SAHS) based on the opti-mized sequential use of nocturnal pulse oximetry and respi-ratory polygraphy (AutoSet®, AS) in patients suspected of SAHS Methods Simultaneous performance of pulse oximetry and AS in 145 patients highly suspected of SAHS (at least two of the following signs or symptoms: chronic snoring, ob-servations of repeated apneic events, and abnormal daytime drowsiness). SAHS was diagnosed when the apnea/hypopnea index (AHI) was greater than or equal to 10, based on AS findings. The diagnostic algorithm was obtained by calcula-ting the prevalence of SAHS, calculating the best diagnostic cutoff point for a desaturation index greater than or equal to 4% (ID4%) based on the AHI; analyzing the positive predic-tive value (PPV) and negative predictive value (NPV) for the cutoff and the correlation and agreement between ID4% and the AHI depending on the presence and severity of SAHS Results The overall prevalence of SAHS was 83.4%. The best cutoff point was obtained using ID4% greater than or equal to 10 (sensitivity 82%; specificity 83%). The PPV and NPV for the prevalence calculated were 0.95 and 0.29, respectively. The correlation between ID4% and AHI was 0.84; overall agreement was 0.93. For patients who did not have SAHS, the PPV was 0.49, and the NPV was 0.35; both gradually increased in cases of mild, moderate and severe SAHS (to 0.90 and 0.95, respectively, for severe SAHS). Using these data we created a diagnostic algorithm accor-ding to which an ID4% greater than or equal to 30 for noc-turnal pulse oximetry (sensitivity 72%, specificity 100%) would indicate that AS testing would be unnecessary. An ID4% less than 30, on the other hand, would lead to further testing (AS, or polysomnography in the event of a negative AS), based on the high prevalence of SAHS in our series Conclusions The sequential use of nocturnal pulse oxi-metry and AS allows substantial savings of polysomnograp-hic testing in groups at high risk of SAHS
    Archivos de Bronconeumología 01/2003; 39(02):74-80. DOI:10.1157/13043587 · 1.82 Impact Factor
Show more